Management Discussion and Analysis has been included in adherence to the spirit enunciated in the code of corporate governance approved by the Securities Exchange Board of India (SEBI)
Management herein presents the industry overview, opportunities and threats, initiatives by the company and its overall strategy and outlook for the future.
BUSINESS OUTLOOK
The Scheme of Arrangement for Re-organisation and Restructuring of the capital of the Company has been approved by the Honble High Court of Judicature at Hyderabad for the state of Andhra Pradesh and Telangana.
INDUSTRIAL OVERVIEW
The company is not carrying on any business. Hence, no over view of the Industry is being given in this report. The company is in the process of restructuring and realigning its activities.
INTERNAL CONTROLS
The Company has adequate internal control mechanism at ail levels of the organisation aimed at promoting. The Company also maintains suitable monitoring procedures in various functional areas.
QUALITY
Your Company firmly believes that quality has to be present in every area of operation of the company. Various continuous quality improvement programmes are built into the annual business and operating plans to sustain inherent efficiency and competitiveness in value delivery to the stake holders and to the society at large.
CAUTIONARY STATEMENT
Statements in the "Management Discussion & Analysis" describing companys strategy, business and financial analysis are in the nature of judgements and forward looking statements. Actual results could differ materially from those expected or implied. Important factors that could make a difference to the companys operations include government regulations, patent laws, tax regime, economic and industrial developments within India and within the pharmaceutical industry / relevant segments in which company operates, financial situation of the company and other external and internal variables in the companys environment,
FOR AND ON BEHALF OF THE BOARD
For Trans Medicare Limited
Sd/-
(Haridass Ramesh)
Director
DIN No:00107388
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.